<DOC>
	<DOCNO>NCT01176487</DOCNO>
	<brief_summary>RATIONALE : 3-dimensional conformal radiation therapy may lessen side effect cause palliative radiation therapy improve quality life patient lung cancer . PURPOSE : This clinical trial study well 3-dimensional conformal radiation therapy work reduce side effect palliative radiation patient lung cancer .</brief_summary>
	<brief_title>Palliative 3-Dimensional Conformal Radiation Therapy Reducing Radiation Side Effects Patients With Lung Cancer . ICORG 06-34</brief_title>
	<detailed_description>The primary purpose study demonstrate use technically sophisticated 3-dimensional conformal radiation therapy palliative treatment lung cancer patient result equivalent degree symptom relief reduction primary endpoint oesophagitis . Single arm therapeutic clinical study . RT Treatment Regimens : 17 Gy/2 fraction 20Gy/5 fraction 39Gy/13 fraction Primary Endpoint : -The occurrence Grade 3 high oesophagitis interval start 1-month post completion treatment determine CTCAE Version 4.02 Patients assessed pre treatment , treatment , 2 week post completion treatment , one month post completion treatment , three month post completion treatment , three monthly thereafter -All patient complete treatment ( whose on-treatment toxicity document ) evaluable . Secondary Endpoint : - Quality Life Assessment . All patient require complete EORTC QLQ-C15-PAL ( Version 1 ) Lung Specific Module ( LC 13 ) - The occurrence AEs Safety Endpoint : -Radio-induced oesophagitis , acute long term , use CTCAE Version 4.02 .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Karnofsky Performance Status &gt; equal 40 % Patients locally advance metastatic small cell nonsmall cell lung cancer The presence intrathoracic symptom require palliative treatment WBI ( require ) permit The patient 's condition must permit wait 3dimensional design process implement . This discretion Consultant Physician Patients present pleural effusion provide pleural effusion prevent reasonably accurate delineation target volume Intrathoracic disease require palliation must clearly evident diagnostic CT scan Life expectancy least 3 month ( assessed clinician ) Provision write informed consent line ICHGCP guideline In opinion Investigator , evidence severe uncontrolled systematic disease ( e.g . unstable uncompensated respiratory , cardiac , hepatic renal disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>